Takeda’s HYQVIA receives approval in Japan for treating immunodeficiencies, offering a more convenient, less frequent subcutaneous infusion option.
Takeda’s HYQVIA Approved in Japan To Treat Immunodeficiency
Where Today's News Shapes Tomorrow
March 5, 2026
Headlines
